Wholesale Medical Use IgG/IgM/NS1 Antibody Antigen Zika Combo Rapid Test Kit
Click to enlarge

Wholesale Medical Use IgG/IgM/NS1 Antibody Antigen Zika Combo Rapid Test Kit

Jiangsu, ChinaEvancare Medical (Nantong) Co., Ltd.

$0.31 - $1.54

MOQ500 Minimum

Lead Time
Quantity旺季淡季
1 - 20005 days5 days
2001 - 1000010 days10 days
10001 - 10000015 days15 days
> 100000To be negotiatedTo be negotiated

Product profile

Format
cassette
Function
Early Detection
Instrument classification
Class II
Safety standard
GB/T18830-2009
Display
screening
Place of Origin
Jiangsu, China
Model Number
EC-zika
Power Source
Manual
Product name
zika test
Material
Medical Grade ABS Plastic
After-sale Service
Online Technical Support
Brand Name
EVANCARE or Customized Logo
Single package size
65X42X38 cm
Shelf Life
3 Years
Supply Ability
1000000 pieces per Day
Accuracy
99%
Quality Certification
CE
Package
Single Pouch + Carton
Packaging Details
1 pcs cassette+ 1 pcs disccant/ pouch, 25 pcs/ gift box, 20 gift box/ carton 1 20Ft container can load 550,000pcs cassettes. 1 40HQ container can load 1650,000pcs cassettes
Method
Colloidal Gold Rapid Test
Single gross weight
20.000 kg
Port of dispatch
SHANGHAI /NINGBO/GUANGZHOU
Warranty
3 Years
Certificate
CE ISO FSC
Selling Units
Single item

Company profile

Evancare Medical (Nantong) Co., Ltd.

南通盈泰医疗器械有限公司
Jiangsu, ChinaRm. 1210, Bldg. 8, Tongfu Fuer Lecheng, Development Area Nantong Jiangsu China
  • CertifiedTrade Assurance
  • Business Type: Trading Company
  • Established: 2018
  • Employees: 11 - 50 People
  • Annual Export Value: US$2.5 Million - US$5 Million
  • Avg. Response Time: ≤ 7h
  • Certification: IVDR

Main Products

  • Dengue Test
  • Malaria Test
  • HCG Test
  • HIV Test
  • Urine Analysis Test

Main Markets

Eastern Asia(18.00%), Africa(15.00%), Southeast Asia(10.00%), Domestic Market(10.00%), South America(9.00%), Western Europe(5.00%), Oceania(5.00%), Eastern Europe(5.00%), North America(5.00%), South Asia(5.00%), Mid East(5.00%), Southern Europe(3.00%), Central America(3.00%), Northern Europe(2.00%)